Juniper Pharmaceuticals Inc is a women's health therapeutic company focused on developing therapeutics that address unmet medical needs in women's health. It offers technical services to the pharmaceutical and biotechnology industry.
| Website: | www.juniperpharma.com |
| Email: | IR@juniperpharma.com |
| Main Phone: | +1 617 639-1500 |
| Address: | 33 Arch Street |
| State: | MA |
| City / Town: | Boston |
| Country: | USA |
| Postal Code: | 02110 |
| Exchange: | NGS |
| CEO: | Alicia Secor |
| Employees: | 155 |
| NAICS: | Pharmaceutical Preparation Manufacturing (325412) |
| Last Price 11.43 | Change $ 0.025 | Change % 0.22 | Tick N/A |
| Bid 11.40 | Bid Size 275,100.00 | Ask 11.45 | Ask Size 75,300.00 |
| Open 11.45 | High 11.45 | Low 11.40 | Prev Close 11.40 |
| Last Trade | Volume 350,827 | 52 Wk Hi 13.25 | 52 Wk Low 4.30 |
| Market Cap 126.9 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 11,104,757.00 | EPS (TTM) 0.01 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 16 |
| Number of Buys | 0 | 13 |
| Number of Sells | 0 | 3 |
| Net Activity | 0 | 182671 |
| Last 10 Buys | Shares |
|---|---|
| James A. Geraghty | 1,000 |
| James A. Geraghty | 1,000 |
| Ann C. Merrifield | 1,000 |
| Frank Murdoch Armstrong | 1,000 |
| James A. Geraghty | 1,000 |
| James A. Geraghty | 1,000 |
| Ann C. Merrifield | 1,000 |
| Nikin Patel | 1,000 |
| Frank C. Condella | 1,000 |
| Nikin Patel | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| N/A | 0 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 34 | 34 | 34 | 34 |
| Low Target Price Estimate | 20 | 20 | 20 | 20 |
| Mean Target Price Estimate | 27 | 27 | 27 | 27 |
| Standard Deviation | 9.9 | 9.9 | 9.9 | 9.9 |
| Date of Most Recent Estimate | 05/18/18 | 05/18/18 | 05/18/18 | 05/18/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| CT ORDER | 1 | 2018-06-14 | |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 78 | 2018-05-10 |
| 8-K | Report of unscheduled material events or corporate changes. | 11 | 2018-05-10 |
| SC 13G/A | Amendment to the SC 13G filing | 1 | 2018-05-08 |
| 10-K/A | Amendment to a previously filed 10-K | 39 | 2018-04-30 |
| 8-K | Report of unscheduled material events or corporate changes. | 7 | 2018-04-25 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-03-22 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-03-22 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-03-21 |
| 10-K | Annual report with a comprehensive overview of the company | 129 | 2018-03-09 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
